Hospira Propofol Injectable Emulsion: Recall - Glass Vial Defect
MedSun: Newsletter #76, September 2012
FDA MedWatch Safety Alert
Recall due to visible particles embedded in the glass to the user level. There may be potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution. In the event in which particulate matter could be injected into a patient, there may be the potential for patient injury where medical intervention may be required
FDA MedWatch Safety Alert. Hospira Propofol Injectable Emulsion: Recall - Glass Vial Defect. August 16, 2012.